feed,title,long_url,short_url
InsiderMonkey,Ultragenyx Pharmaceutical (RARE) Resubmits Biologics License Application for Gene Therapy Treatment,https://insidermonkey.com/blog/--1690681,
InsiderMonkey,Legend Biotech (LEGN) Shakes Up Board,https://insidermonkey.com/blog/--1690683,
InsiderMonkey,Atlassianâ€™s (TEAM) Maintained at Buy by Canaccord Genuity,https://insidermonkey.com/blog/--1690654,
InsiderMonkey,Trade Desk (TTD) Sees Major Divestment from ETF,https://insidermonkey.com/blog/--1690678,
InsiderMonkey,Wave Life Sciences (WVE) Regains Rights to Potential Rare Genetic Disorder Treatment,https://insidermonkey.com/blog/--1690675,
InsiderMonkey,"Monday.com (MNDY) Sees Price Target Cuts from UBS, Piper Sandler",https://insidermonkey.com/blog/--1690671,
InsiderMonkey,HubSpot (HUBS) Price Target Cut in Broad Sweep by Piper Sandler,https://insidermonkey.com/blog/--1690667,
InsiderMonkey,Braze (BRZE) Sees Price Target Cut from Piper Sandler,https://insidermonkey.com/blog/--1690663,
InsiderMonkey,TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan,https://insidermonkey.com/blog/--1690620,
InsiderMonkey,Duolingo (DUOL) Sees Mixed Opinions from Analysts,https://insidermonkey.com/blog/--1690641,
InsiderMonkey,"Roblox Q4 Results Beats Consensus, Guidance Ahead",https://insidermonkey.com/blog/--1690647,
InsiderMonkey,Intapp (INTA) Draws Multiple Price Target Cuts,https://insidermonkey.com/blog/--1690630,
InsiderMonkey,Remitly Global (RELY) Draws Positive Ratings from Analysts,https://insidermonkey.com/blog/--1690635,
